$153 Million is the total value of JNE Partners LLP's 14 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 66.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $9,322,000 | -57.2% | 82,000 | -59.0% | 6.09% | -40.9% |
CP | Exit | CANADIAN PAC RY LTD | $0 | – | -306,300 | -100.0% | -11.97% | – |
CMCSA | Exit | COMCAST CORP NEWcl a | $0 | – | -561,902 | -100.0% | -12.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NOVAGOLD RES INC | 16 | Q3 2023 | 34.9% |
AMERCO | 11 | Q3 2022 | 40.0% |
ELLIOTT OPPORTUNITY II CORP | 9 | Q2 2023 | 19.8% |
COMCAST CORP NEW | 8 | Q1 2022 | 23.5% |
ORION BIOTECH OPPORTUNTES CO | 8 | Q1 2023 | 11.1% |
MSD ACQUISITION CORP | 8 | Q4 2022 | 11.1% |
LIBERTY MEDIA CORP DEL | 8 | Q2 2023 | 13.9% |
ROCKET INTERNET GRWT OPRT CO | 8 | Q4 2022 | 3.2% |
KKR ACQUISITION HOLDING I CO | 7 | Q3 2022 | 1.7% |
MICRON TECHNOLOGY INC | 5 | Q3 2023 | 56.9% |
View JNE Partners LLP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Prevail Therapeutics Inc. | January 29, 2021 | ? | ? |
View JNE Partners LLP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-15 |
View JNE Partners LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.